8-K
Current Report
SUTRO BIOPHARMA, INC. Filed Acc 0001193125-25-223434
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading stro-20250929.htm…